From September 7, 2022 to October 18, 2022, the company has repurchased 463,678 shares, representing 2.97% for KRW 2,944.46 million. With this, the company has completed the repurchase of 463,678 shares, representing 2.97% for KRW 2,944.46 million under the buyback announced on September 7, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,150 KRW | +0.82% | +2.33% | +15.60% |
1st Jan change | Capi. | |
---|---|---|
+15.60% | 72.42M | |
+14.26% | 9.15B | |
-14.54% | 4.9B | |
+42.06% | 4.46B | |
+9.01% | 4.09B | |
+21.43% | 2.49B | |
-27.22% | 2.17B | |
+15.83% | 2.1B | |
-39.50% | 1.89B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- A131030 Stock
- News OPTUS Pharmaceutical Co., Ltd.
- Tranche Update on OPTUS Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 7, 2022.